Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
Human enterovirus 71 (EV71) is a significant cause of morbidity and mortality from Hand, Foot and Mouth Disease (HFMD) and neurological complications, particularly in young children in the Asia-Pacific region. There are no vaccines or antiviral therapies currently available for prevention or treatme...
Saved in:
Main Authors: | Shi-Hsia Hwa (Author), Yock Ann Lee (Author), Joseph N Brewoo (Author), Charalambos D Partidos (Author), Jorge E Osorio (Author), Joseph D Santangelo (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inactivated enterovirus A71 vaccines and moving forward
by: Hiroyuki Shimizu
Published: (2021) -
Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial
by: Yajun Shu, et al.
Published: (2024) -
Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial
by: Yan Li, et al.
Published: (2021) -
Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints
by: Wenbo Zhu, et al.
Published: (2017) -
Enterovirus 71 in Taiwan
by: Luan-Yin Chang
Published: (2008)